• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经性疼痛的管理

Management of neuropathic pain.

作者信息

Jensen Troels S, Finnerup Nanna Brix

机构信息

Department of Neurology and Danish Pain Research Center, Aarhus University, Aarhus, Denmark.

出版信息

Curr Opin Support Palliat Care. 2007 Aug;1(2):126-31. doi: 10.1097/SPC.0b013e3282eeb45f.

DOI:10.1097/SPC.0b013e3282eeb45f
PMID:18685353
Abstract

PURPOSE OF REVIEW

Neuropathic pain is a chronic pain condition arising from injury or disease of the peripheral or central nervous system with a substantial impact on quality of life. This brief review focuses on the increasing evidence for effective treatments and discusses an evidence-based algorithm for treating neuropathic pain conditions.

RECENT FINDINGS

Randomized controlled trials have consistently shown efficacy of tricyclic antidepressants, gabapentin/pregabalin, opioids, tramadol, and serotonin and noradrenaline-reuptake inhibitors for the treatment of various neuropathic pain conditions, lidocaine patches for postherpetic neuralgia and cannabinoids for pain in multiple sclerosis. Carbamazepine or oxcarbazepine is the treatment of choice for trigeminal neuralgia. The efficacy of these drugs in other neuropathic pain conditions as well as the efficacy of lamotrigine and topical capsaicin is questionable, but they may be useful in a subgroup of patients.

SUMMARY

For each patient, considerations on the underlying pain mechanisms, immediate and potential long-term side effects, and price as well as comorbidities and concurrent medications will decide which drug should be the first choice, but until further progress is made towards a mechanism-based classification, treatment is likely to be a trial-and-error process where drug combinations may also be considered.

摘要

综述目的

神经性疼痛是一种由外周或中枢神经系统损伤或疾病引起的慢性疼痛病症,对生活质量有重大影响。本简要综述着重于有效治疗方法的证据日益增多,并讨论一种基于证据的治疗神经性疼痛病症的算法。

最新发现

随机对照试验一直表明,三环类抗抑郁药、加巴喷丁/普瑞巴林、阿片类药物、曲马多以及5-羟色胺和去甲肾上腺素再摄取抑制剂对治疗各种神经性疼痛病症有效,利多卡因贴剂对带状疱疹后神经痛有效,大麻素对多发性硬化症疼痛有效。卡马西平或奥卡西平是三叉神经痛的首选治疗药物。这些药物在其他神经性疼痛病症中的疗效以及拉莫三嗪和外用辣椒素的疗效存在疑问,但它们可能对一部分患者有用。

总结

对于每位患者,对潜在疼痛机制、即刻和潜在的长期副作用、价格以及合并症和同时服用的药物的考虑将决定哪种药物应作为首选,但在基于机制的分类取得进一步进展之前,治疗可能是一个试错过程,其中也可能考虑药物联合使用。

相似文献

1
Management of neuropathic pain.神经性疼痛的管理
Curr Opin Support Palliat Care. 2007 Aug;1(2):126-31. doi: 10.1097/SPC.0b013e3282eeb45f.
2
Pharmacology and treatment of neuropathic pains.神经病理性疼痛的药理学与治疗
Curr Opin Neurol. 2009 Oct;22(5):467-74. doi: 10.1097/WCO.0b013e3283311e13.
3
Pharmacologic treatment of neuropathic pain.神经性疼痛的药物治疗。
Acta Neurol Belg. 2001 Mar;101(1):53-64.
4
[Pharmacological treatment of neuropathic pain].[神经性疼痛的药物治疗]
Rev Neurol (Paris). 1992;148(8-9):521-31.
5
Trends in opioid use for chronic neuropathic pain: a survey of patients pursuing enrollment in clinical trials.慢性神经性疼痛的阿片类药物使用趋势:一项对寻求参加临床试验患者的调查。
Can J Anaesth. 2003 Jan;50(1):42-7. doi: 10.1007/BF03020185.
6
Pharmacotherapy for neuropathic pain.神经性疼痛的药物治疗。
Pain Pract. 2006 Mar;6(1):27-33. doi: 10.1111/j.1533-2500.2006.00055.x.
7
Antidepressants in the treatment of neuropathic pain.抗抑郁药治疗神经性疼痛。
Basic Clin Pharmacol Toxicol. 2005 Jun;96(6):399-409. doi: 10.1111/j.1742-7843.2005.pto_96696601.x.
8
Management of painful neuropathies.疼痛性神经病变的管理
Handb Clin Neurol. 2013;115:279-90. doi: 10.1016/B978-0-444-52902-2.00017-5.
9
Review of current guidelines on the care of postherpetic neuralgia.审查带状疱疹后神经痛护理的现行指南。
Postgrad Med. 2011 Sep;123(5):134-42. doi: 10.3810/pgm.2011.09.2469.
10
The evolving role of antiepileptic drugs in treating neuropathic pain.抗癫痫药物在治疗神经性疼痛中不断演变的作用。
Neurology. 2000;55(5 Suppl 1):S41-6; discussion S54-8.

引用本文的文献

1
Analysis of Penetrating Injuries to the Sciatic Nerve, Highlighting Insights From Sudan.坐骨神经穿透伤分析,重点介绍来自苏丹的见解。
Plast Reconstr Surg Glob Open. 2025 Jun 24;13(6):e6901. doi: 10.1097/GOX.0000000000006901. eCollection 2025 Jun.
2
Emerging Roles of Long Non-coding RNAs in Chronic Neuropathic Pain.长链非编码RNA在慢性神经性疼痛中的新作用
Front Neurosci. 2019 Oct 18;13:1097. doi: 10.3389/fnins.2019.01097. eCollection 2019.
3
Mobile Palliative Care Consultation Service (PCCS): Overview of Hospice and Palliative Care Evaluation (HOPE) Data on In-Patients With End-Stage Cancer, Multiple Sclerosis, and Noncancer, Nonneurological Disease From 4 PCCS Centers in Germany in 2013.
移动姑息治疗咨询服务(PCCS):2013年德国4个PCCS中心对晚期癌症、多发性硬化症以及非癌症、非神经疾病住院患者的临终关怀与姑息治疗评估(HOPE)数据概述
Palliat Care. 2018 Jul 18;11:1178224218785139. doi: 10.1177/1178224218785139. eCollection 2018.
4
Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain.用于治疗慢性神经性疼痛的植物源性大麻素
Medicines (Basel). 2018 Jul 1;5(3):67. doi: 10.3390/medicines5030067.
5
Modulation of pain, nociception, and analgesia by the brain reward center.大脑奖赏中枢对疼痛、伤害感受和镇痛的调节。
Neuroscience. 2016 Dec 3;338:81-92. doi: 10.1016/j.neuroscience.2016.05.017. Epub 2016 May 14.
6
Neuropathic pain referrals to a multidisciplinary pediatric cancer pain service.转诊至多学科儿科癌症疼痛服务机构的神经性疼痛
Pain Manag Nurs. 2014 Mar;15(1):126-31. doi: 10.1016/j.pmn.2012.07.006. Epub 2012 Aug 25.
7
Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey.四氢大麻酚(Δ9-四氢大麻酚)治疗慢性中枢性神经病理性疼痛和纤维肌痛患者:一项多中心调查结果
Anesthesiol Res Pract. 2009;2009. doi: 10.1155/2009/827290. Epub 2009 Oct 25.
8
Fabry disease in children and the effects of enzyme replacement treatment.儿童法布里病及酶替代疗法的效果
Eur J Pediatr. 2009 Nov;168(11):1355-63. doi: 10.1007/s00431-009-0937-9. Epub 2009 Feb 26.
9
Phospholipase C{beta}3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic pain.小鼠和人类背根神经节及脊髓中的磷脂酶Cβ3可能是治疗神经性疼痛的靶点。
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):20004-8. doi: 10.1073/pnas.0810899105. Epub 2008 Dec 9.